Position in ONC
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$9,232,743
+$451,638 QoQ
Shares Held
32,399
+9.6% QoQ
Ownership
0.029%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#59
of 282 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ONC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ASSETMARK, INC holds $347,870,398 across 92 Biotechnology names. ONC ranks #6 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
3,433,824 | $186,834,363 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
61,055 | $30,327,850 | |
| 3 | DFTX |
Definium Therapeutics, Inc.
|
396,542 | $18,653,335 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
174,334 | $13,645,122 | |
| 5 | PTGX |
Protagonist Therapeutics, Inc
|
98,687 | $12,097,052 | |
| 6 | ONC |
BeOne Medicines Ltd.
This page
|
32,399 | $9,232,743 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
12,594 | $7,852,862 | |
| 8 | ARGX |
Argenx SE
|
7,699 | $7,142,901 |
All Filings in ONC
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,232,743 | 32,399 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $8,781,105 | 29,569 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $7,538,741 | 24,814 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $7,829,626 | 22,981 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $5,119,054 | 21,147 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $5,382,433 | 19,776 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $3,424,708 | 18,541 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $3,852,142 | 17,158 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $2,654,803 | 18,608 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $2,608,116 | 16,677 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $2,145,562 | 11,896 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $1,887,196 | 10,492 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $1,699,377 | 9,531 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,857,222 | 8,617 | Shares | Defined | 2023-05-05 | |
| 2022-12-31 | $1,286,429 | 5,849 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $752,025 | 5,578 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $747,423 | 4,618 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $732,899 | 3,886 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $446,492 | 1,648 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $104,544 | 288 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $78,933 | 230 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $79,710 | 229 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $50,127 | 194 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $52,418 | 183 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $29,390 | 156 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $18,958 | 154 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||